| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_830b5db78d87b54fa24eb89247aa27e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c17d407fa3239fecbb8d38d264363cc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0966448beed222b263e4527dad52c122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_abf9a8592d3d48d4510a5a9ac7b58f11 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-35 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 |
| filingDate |
2007-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ae75303b22d86420449b21d5c2f36ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_865a29c6c5e7a6e77280b0cb00cd8096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d4a49ea659570d9e05f638c2b082825 |
| publicationDate |
2007-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007104493-A1 |
| titleOfInvention |
Use for vasoactive intestinal peptide (vip) and the isolated cells stimulated by said peptide |
| abstract |
The invention relates to the use of vasoactive intestinal peptide (VIP) for preparing a medicinal product for autoimmune diseases and/or transplant rejection in mammals. The invention also relates to compositions comprising dendritic cells and/or regulatory T cells that are capable of creating peripheral immune tolerance, and to isolated cells contained therein. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9458218-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8334257-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8841255-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11103558-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8729018-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9821036-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10596230-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9458217-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9328154-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10258700-B2 |
| priorityDate |
2006-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |